Streetbeat News

Products Services

BTCT

BTC Digital Ltd. (NASDAQ:BTCT), a cryptocurrency mining company, has entered into subscription agreements for a private placement of 303,497 ordinary shares at $3.342 per share, raising $1.014M. The investors are not U.S. residents or persons. The proceeds will be used to purchase additional mining machines to increase the company's mining capacity. The transaction is expected to close on January 3, 2024.

Portfolio Pulse from Happy Mohamed

December 26, 2023 | 1:35 pm

MA

Mastercard SpendingPulse reports a 3.1% increase in U.S. retail sales excluding automotive during the 2023 holiday season, with online sales up 6.3% and in-store sales up 2.2% year-over-year. Apparel and restaurant sectors saw increases of 2.4% and 7.8% respectively, while electronics and jewelry declined. The report reflects consumer spending across all payment types and is not adjusted for inflation.

Portfolio Pulse from Happy Mohamed

December 26, 2023 | 1:14 pm

MA

XRT

Mastercard SpendingPulse reports a 3.1% growth in US retail sales, with online sales up by 6.3% and in-store sales rising by 2.2% year-over-year.

Portfolio Pulse from Benzinga Newsdesk

December 26, 2023 | 1:06 pm

CVRX

CVRx, Inc. (NASDAQ:CVRX) announced FDA approval for expanded labeling of Barostim based on long-term data from the BeAT-HF trial. The updated IFU reflects improved functional status and quality of life for heart failure patients. The U.S. market opportunity for Barostim is now estimated at $2.2 billion, a significant increase from previous estimates.

Portfolio Pulse from Happy Mohamed

December 26, 2023 | 1:06 pm

ECOR

electroCore, Inc. (NASDAQ:ECOR) has expanded its intellectual property portfolio with the issuance of two patents related to its non-invasive vagus nerve stimulation (nVNS) technology. The patents, issued on December 26, 2023, cover systems and methods for remote therapy and patient monitoring, and medical devices for treating medical conditions with a focus on dosage and deactivation features.

Portfolio Pulse from Happy Mohamed

December 26, 2023 | 1:04 pm

BCLI

BrainStorm Cell Therapeutics Inc. (NASDAQ:BCLI) has been granted patents in Europe, Australia, and Israel for its NurOwn and NurOwn-Exosomes technologies. These patents cover methods of qualifying cells for treating ALS and the use of specific exosomes derived from MSC-NTF cells for treating neurodegenerative diseases. The grants are expected to strengthen BrainStorm's intellectual property position in the field of neurodegenerative disease treatments.

Portfolio Pulse from Benzinga Newsdesk

December 26, 2023 | 12:31 pm

ASML

INTC

Intel Corporation (NASDAQ:INTC) is set to receive a $3.2 billion grant from the Israeli government for a new $25 billion chip plant in Israel, with operations starting in 2027. Intel has committed to purchasing $16.6 billion in goods and services from Israeli suppliers over the next decade. The company is actively progressing with the construction of the site, which is part of its global supply chain resilience efforts. ASML Holding NV (NASDAQ:ASML) has started shipping components for a new chipmaking machine to Intel's Oregon factory.

Portfolio Pulse from Nabaparna Bhattacharya

December 26, 2023 | 12:02 pm

MIST

Milestone Pharmaceuticals has received a Refusal to File letter from the FDA regarding their New Drug Application for etripamil nasal spray, intended for the treatment of paroxysmal supraventricular tachycardia.

Portfolio Pulse from Benzinga Newsdesk

December 26, 2023 | 12:02 pm

AZN

GRCL

AstraZeneca Plc (NASDAQ:AZN) is set to acquire Gracell Biotechnologies Inc (NASDAQ:GRCL) to enhance its cell therapy portfolio. The deal is valued at $2.00/share plus a contingent value right of $0.30/share, totaling approximately $1.2 billion if all conditions are met. The acquisition includes GC012F, a CAR-T therapy for multiple myeloma and other diseases. Gracell's shares surged 63.3% in premarket trading after the announcement.

Portfolio Pulse from Vandana Singh

December 26, 2023 | 11:47 am

AULT

Ault Alliance forecasts FY24 revenues to range from $230M to $240M, driven by growth in its Sentinum brand, data center operations, and Bitcoin mining sector. The company's crane rental business is also expected to contribute to this performance.

Portfolio Pulse from Benzinga Newsdesk

December 26, 2023 | 11:38 am